Home › Companies › ITEOS THERAPEUTICS INC. › 2024-2025
At ITEOS THERAPEUTICS INC.'s shareholder meeting held June 17, 2025, in the 2024-2025 proxy season, 53 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 567 separate fund positions. On the most widely held item on that ballot — Election of the Class II director nominees to serve until the 2028 Annual Meeting of… — ITEOS THERAPEUTICS INC.'s filing reports the nominee as elected, with 73% support of the votes cast (FOR divided by FOR plus WITHHELD, because this ballot offered only for and withhold; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: ITEOS THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 17, 2025.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and ITEOS THERAPEUTICS INC.’s Form 8-K, filed June 17, 2025 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 17, 2025: 4 items on ITEOS THERAPEUTICS INC.’s Form 8-K, filed June 17, 2025: 3 elected · 1 approved.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024 2024-2025
Explore ITEOS THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are ITEOS THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 17, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Tony Ho | 21,907,643 | -- | -- | 6,775,693 | 4,871,628 | 76% | Elected | — |
| Elect Director: Robert Iannone | 24,909,798 | -- | -- | 3,773,538 | 4,871,628 | 87% | Elected | — |
| Elect Director: Ann D. Rhoads | 20,985,311 | -- | -- | 7,698,026 | 4,871,627 | 73% | Elected | — |
| Company's stockholders approved the ratification of Deloitte Bedrijfsrevisoren / Réviseurs d'Entreprises BV/SRL as the Company's independent registered public account firm. | 33,347,344 | 24,081 | 183,538 | -- | 1 | 99.9% | Approved | — |
Source: ITEOS THERAPEUTICS INC., Form 8-K, filed with the SEC on June 17, 2025 — read the filing on EDGAR.
Each item below shows how the 53 asset managers that disclosed a ITEOS THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
73% Majority: yes · of votes cast
Description as filed by funds: Election of the Class II director nominees to serve until the 2028 Annual Meeting of Stockholders: Ann D. Rhoads
ITEOS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Ann D. Rhoads”): 20,985,311 for, 7,698,026 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final voting results for the Annual Meeting are as follows: The Company's stockholders elected each of the Class II director nominees.”
Support: 73% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 5,012,065 for, 1,062,250 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,722,373 | 0 | 0 | 0 | For |
| BlackRock | 1,601,288 | 0 | 0 | 0 | For |
| JPMorgan | 585,089 | 0 | 0 | 0 | For |
| TIAA | 302,949 | 0 | 0 | 0 | For |
| Charles Schwab | 239,610 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 0 | 196,582 | Withhold |
| Nationwide | 8,001 | 0 | 0 | 146,076 | Mixed |
| Brighthouse | 95,950 | 0 | 0 | 29,810 | Mixed |
| AIG/SunAmerica | 0 | 0 | 0 | 112,653 | Withhold |
| Victory Capital | 0 | 0 | 0 | 101,860 | Withhold |
| Equitable | 48,660 | 0 | 0 | 39,460 | Mixed |
| American Century | 0 | 0 | 0 | 76,837 | Withhold |
| SEI | 75,171 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,290 | 0 | 0 | 18,800 | Mixed |
| GuideStone | 0 | 0 | 0 | 61,200 | Withhold |
| Fidelity | 55,194 | 0 | 0 | 2,900 | For |
| MASTER INVESTMENT PORTFOLIO | 55,281 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 44,391 | 0 | 0 | 4,274 | Mixed |
| Thrivent | 0 | 0 | 0 | 47,884 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 45,379 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 45,035 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 35,000 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 28,646 | Withhold |
| TARGET PORTFOLIO TRUST | 28,000 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 0 | 0 | 18,018 | Withhold |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Description as filed by funds: Election of the Class II director nominees to serve until the 2028 Annual Meeting of Stockholders: Robert Iannone
ITEOS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Robert Iannone”): 24,909,798 for, 3,773,538 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final voting results for the Annual Meeting are as follows: The Company's stockholders elected each of the Class II director nominees.”
Support: 87% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 4,796,330 for, 1,277,985 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,722,373 | 0 | 0 | 0 | For |
| BlackRock | 895,232 | 0 | 0 | 706,056 | Mixed |
| JPMorgan | 585,089 | 0 | 0 | 0 | For |
| TIAA | 302,949 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 239,610 | Withhold |
| Columbia Threadneedle | 196,582 | 0 | 0 | 0 | For |
| Nationwide | 154,077 | 0 | 0 | 0 | For |
| Brighthouse | 113,400 | 0 | 0 | 12,360 | Mixed |
| AIG/SunAmerica | 112,653 | 0 | 0 | 0 | For |
| Victory Capital | 101,860 | 0 | 0 | 0 | For |
| Equitable | 48,660 | 0 | 0 | 39,460 | Mixed |
| American Century | 76,837 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 75,171 | Withhold |
| Lincoln Financial | 63,090 | 0 | 0 | 0 | For |
| GuideStone | 61,200 | 0 | 0 | 0 | For |
| Fidelity | 2,900 | 0 | 0 | 55,194 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 55,281 | Withhold |
| Exchange Place Advisors Trust | 4,274 | 0 | 0 | 44,391 | Mixed |
| Thrivent | 47,884 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 45,379 | 0 | 0 | 0 | For |
| Voya | 45,035 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 35,000 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 28,646 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 28,000 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,018 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
Description as filed by funds: Election of the Class II director nominees to serve until the 2028 Annual Meeting of Stockholders: Tony Ho
ITEOS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Tony Ho”): 21,907,643 for, 6,775,693 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final voting results for the Annual Meeting are as follows: The Company's stockholders elected each of the Class II director nominees.”
Support: 76% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 5,250,099 for, 824,216 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,722,373 | 0 | 0 | 0 | For |
| BlackRock | 1,601,288 | 0 | 0 | 0 | For |
| JPMorgan | 585,089 | 0 | 0 | 0 | For |
| TIAA | 302,949 | 0 | 0 | 0 | For |
| Charles Schwab | 239,610 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 196,582 | 0 | 0 | 0 | For |
| Nationwide | 8,001 | 0 | 0 | 146,076 | Mixed |
| Brighthouse | 95,950 | 0 | 0 | 29,810 | Mixed |
| AIG/SunAmerica | 0 | 0 | 0 | 112,653 | Withhold |
| Victory Capital | 0 | 0 | 0 | 101,860 | Withhold |
| Equitable | 48,660 | 0 | 0 | 39,460 | Mixed |
| American Century | 0 | 0 | 0 | 76,837 | Withhold |
| SEI | 75,171 | 0 | 0 | 0 | For |
| Lincoln Financial | 63,090 | 0 | 0 | 0 | For |
| GuideStone | 0 | 0 | 0 | 61,200 | Withhold |
| Fidelity | 55,194 | 0 | 0 | 2,900 | For |
| MASTER INVESTMENT PORTFOLIO | 55,281 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 44,391 | 0 | 0 | 4,274 | Mixed |
| Thrivent | 0 | 0 | 0 | 47,884 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 45,379 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 45,035 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 35,000 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 28,646 | Withhold |
| TARGET PORTFOLIO TRUST | 28,000 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 0 | 0 | 18,018 | Withhold |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: TO RATIFY THE APPOINTMENT OF DELOITTE BEDRIJFSREVISOREN / REVISEURS D'ENTREPRISES BV/SRL AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.
ITEOS THERAPEUTICS INC.’s own tally for this item (“The Company's stockholders approved the ratification of Deloitte Bedrijfsrevisoren / Réviseurs d'Entreprises BV/SRL as the Company's independent registered public account firm.”): 33,347,344 for, 24,081 against — passed, per its Form 8-K filed June 17, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the ratification of Deloitte Bedrijfsrevisoren / Réviseurs d'Entreprises BV/SRL as the Company's independent registered public account firm.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 6,061,955 for, 12,360 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,722,373 | 0 | 0 | 0 | For |
| BlackRock | 1,601,288 | 0 | 0 | 0 | For |
| JPMorgan | 585,089 | 0 | 0 | 0 | For |
| TIAA | 302,949 | 0 | 0 | 0 | For |
| Charles Schwab | 239,610 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 196,582 | 0 | 0 | 0 | For |
| Nationwide | 154,077 | 0 | 0 | 0 | For |
| Brighthouse | 113,400 | 0 | 12,360 | 0 | Mixed |
| AIG/SunAmerica | 112,653 | 0 | 0 | 0 | For |
| Victory Capital | 101,860 | 0 | 0 | 0 | For |
| Equitable | 88,120 | 0 | 0 | 0 | For |
| American Century | 76,837 | 0 | 0 | 0 | For |
| SEI | 75,171 | 0 | 0 | 0 | For |
| Lincoln Financial | 63,090 | 0 | 0 | 0 | For |
| GuideStone | 61,200 | 0 | 0 | 0 | For |
| Fidelity | 58,094 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 55,281 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 48,665 | 0 | 0 | 0 | For |
| Thrivent | 47,884 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 45,379 | 0 | 0 | 0 | For |
| Voya | 45,035 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 35,000 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 28,646 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 28,000 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,018 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 38,273,795 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.50% |
| 2 | BlackRock | 4.18% |
| 3 | JPMorgan | 1.53% |
| 4 | TIAA | 0.79% |
| 5 | Charles Schwab | 0.63% |
| 6 | Columbia Threadneedle | 0.51% |
| 7 | Nationwide | 0.40% |
| 8 | Brighthouse | 0.33% |
| 9 | AIG/SunAmerica | 0.29% |
| 10 | Victory Capital | 0.27% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| EcoR1 Capital, LLC | 27.93% | 13D |
| BlackRock | 11.78% | 13F |
| BlackRock Portfolio Management LLC | 6.09% | 13G |
| RA Capital Management, L.P. | 5.58% | 13D |
| JPMorgan Chase | 5.18% | 13F |
| ANSBERT GADICKE | 4.71% | 13D |
| Vanguard Group | 4.51% | 13F |
| Citadel Advisors | 3.29% | 13F |
| Dimensional Fund Advisors | 3.09% | 13F |
| Geode Capital | 1.70% | 13F |
Percentages above are of 38,273,795 shares outstanding, as reported by ITEOS THERAPEUTICS INC. on its Form 10-Q dated April 22, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ITEOS THERAPEUTICS INC.’s 10-Q dated April 22, 2025. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
ITEOS THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page).
proxyvotesnow.com, “ITEOS THERAPEUTICS INC. 2025 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/iteos-therapeutics-inc/2025 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.